Quality Improvement Project To Study The Role Of A Cardiologist In Prescription Of Sglt2 Inhibitors In Patients With Heart Failure

Sodium-Glucose coTransporter 2 inhibitors (SGLT2i) medication is FDA approved for first-line guideline-directed medical therapy for the treatment of heart failure irrespective of diabetic status. Common examples of SGLT2i used include Empagliflozin and Dapagliflozin and the contraindications of these are GFR

Source: Journal of Cardiac Failure - January 1, 2024 Category: Cardiology Authors: Aanchal Sawhney, Muhammad Tahir, Hui Chong Lau, Aamir Hayat, Ramanpreet Maan, Rahul Patel, Jonathan Finkel Tags: 076 Source Type: research